Jaguar Health JAGX
NASDAQ JAGX
$3.95 -0.55 (-12.22%)
At close: Oct 1, 2026 · 4:00 PM EDT

Jaguar Health (JAGX) Non-Current Deferred Tax Liability (2017 - 2019)

Updated

Jaguar Health (JAGX) reported Non-Current Deferred Tax Liability of $20,594 for Q4 2019.

Analysis

Jaguar Health (JAGX) Non-Current Deferred Tax Liability (2017 - 2019) Analysis & Trends

  • The Q4 2019 figure ranks as the highest quarterly Non-Current Deferred Tax Liability since Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Jaguar Health 720,234.00 -16.53 Mn 194,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 20,594.00
Sep 30, 2017 990,549.00
API Access

Jaguar Health Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=JAGX&period=max&api_key=YOUR_API_KEY